| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |